cyclopentane has been researched along with Diarrhea in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ariyasu, Y; Ishii, S; Itoh, Y; Komeda, T; Sanekata, M; Shimada, J; Yoshikawa, T | 2 |
Bartelloni, PJ; Beisel, WR; Dupont, HL; Hornick, RB; Klainer, AS; Pekarek, RS; Wannemacher, RW | 1 |
Lippmann, W | 1 |
4 other study(ies) available for cyclopentane and Diarrhea
Article | Year |
---|---|
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): a drug use investigation.
Topics: Acids, Carbocyclic; Administration, Intravenous; Adolescent; Adult; Aged; Antiviral Agents; Cyclopentanes; Diarrhea; Female; Guanidines; Humans; Influenza, Human; Japan; Male; Middle Aged; Nausea; Neuraminidase; Product Surveillance, Postmarketing; Time Factors; Vomiting; Young Adult | 2014 |
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation.
Topics: Acids, Carbocyclic; Adolescent; Antiviral Agents; Child; Child Behavior Disorders; Child, Preschool; Cyclopentanes; Diarrhea; Enzyme Inhibitors; Female; Guanidines; Humans; Infant; Infant, Newborn; Influenza, Human; Injections, Intravenous; Male; Neuraminidase; Product Surveillance, Postmarketing; Treatment Outcome | 2015 |
Detection of a leukocytic endogenous mediator-like mediator of serum amino acid and zinc depression during various infectious illnesses.
Topics: Abscess; Animals; Bacterial Infections; Carbon Radioisotopes; Carboxylic Acids; Cyclopentanes; Diarrhea; Humans; Leucine; Leukocytes; Liver; Rats; Shigella flexneri; Staphylococcus; Typhoid Fever; Virus Diseases; Zinc | 1975 |
Inhibition of gastric acid secretion in the rat by orally-administered synthetic prostaglandin analogues: enantiomorphs of 15-hydroxy-15-methyl-9-oxoprostanoic acid.
Topics: Animals; Cyclopentanes; Depression, Chemical; Diarrhea; Fatty Acids; Gastric Juice; Keto Acids; Mice; Molecular Conformation; Prostaglandins; Rats; Stereoisomerism; Structure-Activity Relationship | 1974 |